Ariceum Therapeutics logo

Ariceum Therapeutics

Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy.

3

Funding Rounds

$78.1m

Money raised

Overview

Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy.

Funding

Funding series

Funding Series Analysis

The company Ariceum Therapeutics has raised a total of $78.1m in funding over 3 rounds.

Key Insights:

  • Ariceum Therapeutics April 2023 Series A Funding Round: $25m
  • Ariceum Therapeutics Series A round, June 2022: $26.1m
  • Ariceum Therapeutics June 2022 Series A Funding Round: $27m
Ariceum Therapeutics logo
Ariceum Therapeutics April 2023 Series A Funding Round $25m
Ariceum Therapeutics logo
Ariceum Therapeutics Series A round, June 2022 $26.1m
Ariceum Therapeutics logo
Ariceum Therapeutics June 2022 Series A Funding Round $27m

Industries

Ariceum Therapeutics is active in the following industries: